Aptose Biosciences Net Asset
| APTODelisted Stock | USD 2.01 0.91 82.73% |
As of the 16th of February 2026, Aptose Biosciences shows the Standard Deviation of 10.3, mean deviation of 6.65, and Risk Adjusted Performance of (0.1). Aptose Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aptose Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aptose Biosciences' valuation are provided below:Aptose Biosciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Aptose |
Search Suggestions
| AP | Ampco Pittsburgh | Company |
| APO-PA | Apollo Global Management | Company |
| APBDX | Bond Fund Investor | Mutual Fund |
| APCB | Trust For Professional | ETF |
| APT | Aptos | Cryptocurrency |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Aptose Biosciences has a Net Asset of 10.13 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Aptose Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptose Biosciences' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics of similar companies.Aptose Biosciences is currently under evaluation in net asset category among its peers.
Aptose Fundamentals
| Return On Equity | -6.94 | |||
| Return On Asset | -1.42 | |||
| Current Valuation | 9.69 M | |||
| Shares Outstanding | 2.55 M | |||
| Shares Owned By Insiders | 24.80 % | |||
| Shares Owned By Institutions | 11.51 % | |||
| Number Of Shares Shorted | 53.15 K | |||
| Price To Earning | (1.80) X | |||
| Price To Book | 67.84 X | |||
| EBITDA | (36.15 M) | |||
| Net Income | (25.43 M) | |||
| Cash And Equivalents | 62.41 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 621 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.89 X | |||
| Book Value Per Share | (14.04) X | |||
| Cash Flow From Operations | (35.98 M) | |||
| Short Ratio | 0.14 X | |||
| Earnings Per Share | (36.38) X | |||
| Target Price | 12.5 | |||
| Number Of Employees | 35 | |||
| Beta | 1.13 | |||
| Market Capitalization | 4.36 M | |||
| Total Asset | 10.13 M | |||
| Retained Earnings | (540.97 M) | |||
| Working Capital | 5.07 M | |||
| Current Asset | 14.98 M | |||
| Current Liabilities | 1.7 M | |||
| Net Asset | 10.13 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Aptose Stock
Moving against Aptose Stock
| 0.89 | USPH | US Physicalrapy | PairCorr |
| 0.85 | CGECF | Cogeco Inc | PairCorr |
| 0.84 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.83 | GS | Goldman Sachs Group | PairCorr |
| 0.82 | GRBK | Green Brick Partners | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |